Who We Are

Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.
Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.
Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.
Key Issues
Causes We Care About, and So Should You!

HIV
Promote necessary funding, programs, and policies to end the HIV epidemic in the United States

HEPATITIS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States

HEALTHCARE ACCESS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States
Facebook posts by @HIV+Hep
Uncertain road ahead for lenacapavir, a new ‘breakthrough’ HIV prevention drug
positivelyaware.com
All last year, the data on drugmaker Gilead Sciences’ injectable lenacapavir for HIV prevention (PrEP) were absolutely breathless. Studies of the PrEP drug for young women at risk for HIV in Africa...Unpacking the 25% HHS budget cut proposed by the Trump administration
www.fiercehealthcare.com
A recent budget document prepared by the White House is giving new clarity over how the Department of Health and Human Services (HHS) could operate for fiscal year 2026. | HIV and cancer prevention ad...